Liu C,Bayer A,Cosgrove SE,Daum RS,Fridkin SK,Gorwitz RJ .2011 .Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant staphylococcus aureus infections in adults and children: Executive summary. Clin Infect Dis, 52(3) : 285-92.
Klevens RM,Edwards JR,Tenover FC,McDonald LC,Horan T,Gaynes R .2006 .Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals,. Clin Infect Dis, 42(3) : 389-91.
. .Technical sheet vancomycin Pfizer 500 mg powder for concentrate for solution for infusion EFG. , : .
Horn JR,Hansten PD,Chan LN .2007 .Proposal for a new tool to evaluate drug interaction cases. , 41(4) : 674-80.
Fanos V,Cataldi L .2001 .Renal transport of antibiotics and nephrotoxicity: A review. J Chemother, 13(5) : 461-72.
Pea F,Furlanut M. .2001 .Pharmacokinetic aspects of treating infections in the intensive care unit: Focus on drug interactions. Clin Pharmacokinet, 40(11) : 833-68.
Wang W,Zheng N,Zhang J,Huang X,Yu S .2017 .Effect of efflux transporter inhibition on the distribution of fluconazole in the rat brain. Neurochem Res, 42(8) : 2274-81.
Guo X,Meng Q,Liu Q,Wang C,Sun H,Peng J .2013 .function of Oat1 and Oat3 in rats. Toxicol Appl Pharmacol, 271(2) : 285-95.
Liu T,Meng Q,Wang C,Liu Q,Guo X,Sun H .2012 .Changes in expression of renal Oat1, Oat3, and Mrp2 in cisplatin-induced acute renal failure after treatment of JBP485 in rats. Toxicol Appl Pharmacol, 264(3) : 423-30.
Fransson M,Helldén A,Östholm Balkhed Å,Nezirević Dernroth D,Ha M,Haglund M .2021 .Case report: Subtherapeutic vancomycin and meropenem concentrations due to augmented renal clearance in a patient with intracranial infection caused by streptococcus intermedius. Front Pharmacol, 12 : 728075.